Cargando…
First‐in‐man allopregnanolone use in super‐refractory status epilepticus
Super‐refractory status epilepticus (SRSE) is associated with high morbidity and mortality. Treatment of SRSE is complicated by progressive cortical hyperexcitability believed to result in part from synaptic GABA receptor internalization and desensitization. Allopregnanolone, a neurosteroid that pos...
Autores principales: | Vaitkevicius, Henrikas, Husain, Aatif M., Rosenthal, Eric S., Rosand, Jonathan, Bobb, Wendell, Reddy, Kiran, Rogawski, Michael A., Cole, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454395/ https://www.ncbi.nlm.nih.gov/pubmed/28589168 http://dx.doi.org/10.1002/acn3.408 |
Ejemplares similares
-
Brexanolone as adjunctive therapy in super‐refractory status epilepticus
por: Rosenthal, Eric S., et al.
Publicado: (2017) -
Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open‐label, dose‐finding, phase 2 trial
por: Vaitkevicius, Henrikas, et al.
Publicado: (2022) -
Intravenous ganaxolone in pediatric super-refractory status epilepticus: A single hospital experience
por: Singh, Rani K., et al.
Publicado: (2022) -
Refractory and Super-refractory Status Epilepticus
por: Samanta, Debopam, et al.
Publicado: (2020) -
Super Refractory Status Epilepticus
por: Zachariah, Joseph, et al.
Publicado: (2016)